In a short video, we’re going to talk about how one of our clients is planning to do a clinical study, and they want to share the participant data with a third party for analysis. Now, how do they do that with HIPAA? They have to share the data on a blind basis. Let’s explain.

Hi, I’m Michael H. Cohen, founding attorney, Cohen Healthcare Law Group. And our job is to help healthcare industry clients like you navigate the complex and often mystifying terrain of healthcare and FDA law, including HIPAA, so you can grow your healthcare venture.

So, yeah, it’s good to comply with HIPAA. Specifically, here, there are very specific de-identification standards which are going to require you to strip away certain categories of personally identifiable information from records before releasing them to a third party. And this is the method.

It’s kind of a safe harbor under HIPAA. HIPAA is excruciatingly detailed, and we can help you get through the de identification agreement and some of these basics along your way.

We look forward to working with you. Please give us a call, and we wish you the best on your continuing journey toward business.